Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
HHS
Secretary Azar Announces Demonstration Opportunities to Expand IMD Coverage
In a November 13, 2018, speech to the annual conference of the National Association of Medicaid Directors (NAMD), United States…
Azar Outlines Agency Strategy Focused on Value
In a speech before the Patient-Centered Primary Care Collaborative Conference, HHS Secretary Alex Azar outlined the agency’s…
Notice of Proposed Rulemaking Issued on 340B Program
The Trump Administration recently released a Notice of Proposed Rulemaking regarding regulatory changes to the 340B program since…
HHS Unveils New Plan for Prescription Prices for Medicare Part B Drugs
On Thursday, October 25, 2018, the United States Department of Health and Human Services (HHS) and the Centers for Medicare &…
HHS Proposes New DTC Advertising Requirement
For our daily readers, you may have seen our post yesterday about the Pharmaceutical and Research Manufacturers of America (PhRMA)…
HHS Claims Lower Drug Prices Following “American Patients First” Blueprint
On May 11, 2018, the White House announced its American Patients First Blueprint aimed at reducing drug prices. Following the…
Is HHS Committed to Lowering Drug Prices?
On Tuesday, June 12, 2018, United States Health and Human Services (HHS) Secretary Alex Azar appeared before the United States…
Senate Confirmation Hearing for Alex Azar – Open Payments to Remain…
On January 9, 2018, the Senate Finance Committee held a nomination hearing for Alex Azar, President Trump’s pick to lead the…
HHS OIG Releases Report on Potential Drug Misclassifications
A report recently released by the Department of Health and Human Services (HHS) Office of Inspector General (OIG) found that…
Trump Nominates Alex Azar to Head HHS
A few weeks ago, President Donald Trump nominated Alex Azar to lead the Department of Health and Human Services (HHS), following…